Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
Public ClinicalTrials.gov record NCT02640092. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Patients With Prodromal, Mild, and Moderate Alzheimer's Disease Compared to Healthy Volunteers
Study identification
- NCT ID
- NCT02640092
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Genentech, Inc.
- Industry
- Enrollment
- 72 participants
Conditions and interventions
Conditions
Interventions
- [18F]GTP1 Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 22, 2015
- Primary completion
- Jun 10, 2019
- Completion
- Jun 10, 2019
- Last update posted
- Dec 22, 2019
2015 – 2019
United States locations
- U.S. sites
- 16
- U.S. states
- 9
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Molecular NeuroImaging | New Haven | Connecticut | 06510 | — |
| KI Health Partners, LLC; New England Institute for Clinical Research | Stamford | Connecticut | 06905 | — |
| Neuropsychiatric Research; Center of Southwest Florida | Fort Myers | Florida | 33912 | — |
| Miami Jewish Health Systems | Miami | Florida | 33137 | — |
| Bioclinica Research | Orlando | Florida | 32806 | — |
| Emory University | Atlanta | Georgia | 30303 | — |
| NeuroStudies.net, LLC | Decatur | Georgia | 30033 | — |
| Acadia Clinical Research; Dr. Henderson's Office | Bangor | Maine | 04401 | — |
| Donald S. Marks, M.D., P.C.; Medical Center | Plymouth | Massachusetts | 02360 | — |
| Alzheimers Disease Center | Quincy | Massachusetts | 02169 | — |
| NeuroCognitive Institute | Mount Arlington | New Jersey | 07856 | — |
| Bio Behavioral Health | Toms River | New Jersey | 08755 | — |
| Advanced Medical Research | Maumee | Ohio | 43537 | — |
| Lehigh Center Clinical Research | Allentown | Pennsylvania | 18104 | — |
| Rhode Island Mood & Memory Research Institute | East Providence | Rhode Island | 02914 | — |
| Butler Hospital | Providence | Rhode Island | 02906 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02640092, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 22, 2019 · Synced May 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02640092 live on ClinicalTrials.gov.